Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus
Jian Hua Li, Chung‐Lin Chou, Bo Li, et al.
Journal of Clinical Investigation (2009) Vol. 119, Iss. 10, pp. 3115-3126
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
David F. Woodward, Rebecca L. Jones, S. Narumiya
Pharmacological Reviews (2011) Vol. 63, Iss. 3, pp. 471-538
Open Access | Times Cited: 412
Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus
Detlef Böckenhauer, Daniel G. Bichet
Nature Reviews Nephrology (2015) Vol. 11, Iss. 10, pp. 576-588
Closed Access | Times Cited: 278
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Nephrogenic Diabetes Insipidus: Essential Insights into the Molecular Background and Potential Therapies for Treatment
Hanne B. Moeller, Søren Rittig, Robert A. Fenton
Endocrine Reviews (2013) Vol. 34, Iss. 2, pp. 278-301
Open Access | Times Cited: 196
E-type prostanoid receptor 4 (EP4) in disease and therapy
Viktória Kónya, Gunther Marsche, Rufina Schuligoi, et al.
Pharmacology & Therapeutics (2013) Vol. 138, Iss. 3, pp. 485-502
Open Access | Times Cited: 144
Renal aquaporins and water balance disorders
Marleen L. A. Kortenoeven, Robert A. Fenton
Biochimica et Biophysica Acta (BBA) - General Subjects (2013) Vol. 1840, Iss. 5, pp. 1533-1549
Closed Access | Times Cited: 143
Aquaporins in kidney pathophysiology
Yumi Noda, Eisei Sohara, Eriko Ohta, et al.
Nature Reviews Nephrology (2010) Vol. 6, Iss. 3, pp. 168-178
Closed Access | Times Cited: 142
Congenital nephrogenic diabetes insipidus: the current state of affairs
Daniel Wesche, Peter M.T. Deen, Nine V.A.M. Knoers
Pediatric Nephrology (2012) Vol. 27, Iss. 12, pp. 2183-2204
Closed Access | Times Cited: 117
Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus
Emma T. B. Olesen, Michael Rützler, Hanne B. Moeller, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 31, pp. 12949-12954
Open Access | Times Cited: 117
New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells
Dennis Brown, Richard Bouley, Teodor G. Păunescu, et al.
AJP Cell Physiology (2012) Vol. 302, Iss. 10, pp. C1421-C1433
Open Access | Times Cited: 87
PGE2, Kidney Disease, and Cardiovascular Risk
Rania Nasrallah, Ramzi Hassouneh, Richard Hébert
Journal of the American Society of Nephrology (2015) Vol. 27, Iss. 3, pp. 666-676
Open Access | Times Cited: 83
Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant)
Daniel G. Bichet, Detlef Böckenhauer
Best Practice & Research Clinical Endocrinology & Metabolism (2016) Vol. 30, Iss. 2, pp. 263-276
Closed Access | Times Cited: 78
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update
Serena Milano, Monica Carmosino, Andrea Gerbino, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2385-2385
Open Access | Times Cited: 76
Antidiuretic Action of Collecting Duct (Pro)Renin Receptor Downstream of Vasopressin and PGE2 Receptor EP4
Fei Wang, Xiaohan Lu, Kexin Peng, et al.
Journal of the American Society of Nephrology (2016) Vol. 27, Iss. 10, pp. 3022-3034
Open Access | Times Cited: 73
Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway
Fumiaki Ando, Eisei Sohara, Tetsuji Morimoto, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 61
Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases
Emma T. B. Olesen, Robert A. Fenton
Nature Reviews Nephrology (2021) Vol. 17, Iss. 11, pp. 765-781
Closed Access | Times Cited: 54
Aquaporin 2 Promotes Cell Migration and Epithelial Morphogenesis
Ying Chen, William L. Rice, Zhizhan Gu, et al.
Journal of the American Society of Nephrology (2012) Vol. 23, Iss. 9, pp. 1506-1517
Open Access | Times Cited: 68
Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice
Giuseppe Procino, Serena Milano, Monica Carmosino, et al.
Kidney International (2014) Vol. 86, Iss. 1, pp. 127-138
Open Access | Times Cited: 66
Is There a Role for PGE2 in Urinary Concentration?
Emma T. B. Olesen, Robert A. Fenton
Journal of the American Society of Nephrology (2012) Vol. 24, Iss. 2, pp. 169-178
Open Access | Times Cited: 65
Concordance of Changes in Metabolic Pathways Based on Plasma Metabolomics and Skeletal Muscle Transcriptomics in Type 1 Diabetes
Tumpa Dutta, High Seng Chai, Lawrence E. Ward, et al.
Diabetes (2012) Vol. 61, Iss. 5, pp. 1004-1016
Open Access | Times Cited: 64
Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts
Min Gao, Rong Cao, Shengnan Du, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 27, pp. 8397-8402
Open Access | Times Cited: 62
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells—a Potential Target for Pharmacological Intervention in Cardiovascular Diseases
Tanja Vukićević, Maike Schulz, Dörte Faust, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 53
Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts
Janet D. Klein, Yanhua Wang, Mitsi A. Blount, et al.
AJP Renal Physiology (2016) Vol. 310, Iss. 10, pp. F1008-F1012
Open Access | Times Cited: 51
Metformin improves urine concentration in rodents with nephrogenic diabetes insipidus
Orhan Efe, Janet D. Klein, Lauren M. LaRocque, et al.
JCI Insight (2016) Vol. 1, Iss. 11
Open Access | Times Cited: 49
Fluvastatin modulates renal water reabsorption in vivo through increased AQP2 availability at the apical plasma membrane of collecting duct cells
Giuseppe Procino, Claudia Barbieri, Monica Carmosino, et al.
Pflügers Archiv - European Journal of Physiology (2011) Vol. 462, Iss. 5, pp. 753-766
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top